Skip to main content

Elevance Health, Inc. statistics

  • ELV · NYSE
  • Insurance
  • Managed Health Care
  • S&P 500
$429.69−0.05%Close 13 Nov 2026 · Market value $95.73B

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

Elevance Health, Inc. is valued at $95.73B on its latest close. Its price is 18.6 times its earnings.

Market value$95.73B
Enterprise value$88.04B
Price / earnings18.63
Price / sales0.47
Price / book2.14
EV / EBITDA12.73
EV / sales0.44
Price / free cash flow14.70
Price / free cash flow, own 5-year average29.84
EV / EBIT16.73
EV / free cash flow13.94
Free cash flow yield6.8%
Dividend yield1.6%

Share price

Latest close$429.69
Day's change−0.0%
52-week high$450.69
52-week low$274.84
From 52-week high−4.7%
Return · 1 month+0.3%
Return · 3 months+8.4%
Return · year to date+22.6%
Return · 1 year+31.2%
Beta · 1 year against the S&P 5000.29
50-day average$415.40
200-day average$375.50
RSI 1454.9
Average volume · 20 sessions1.4M

Margins and returns

For fiscal 2025, as filed.

Operating margin3.6%
Net margin2.8%
Free cash flow margin1.6%
Return on equity13.3%
Return on assets5.1%
Return on invested capital10.1%
Return on invested capital, 5-year average12.0%
Return on capital employed9.2%
Stock-based compensation / revenue0.1%

Financial position

At the end of fiscal 2025.

Cash and equivalents$9.49B
Total debt$32.71B
Net debt−$2.67B
Current ratio1.54
Quick ratio0.76
Debt / equity0.75
Net debt / EBITDA−0.31
Interest coverage5.13

Growth

Revenue, latest quarter on a year+1.4%
Revenue, twelve months on a year+3.6%
EPS, latest quarter on a year+17.9%
EPS, twelve months on a year−3.9%
Revenue, 5-year compound+10.3%
Revenue, 10-year compound+9.7%
Net income, 5-year compound+4.4%
Free cash flow, 5-year compound−20.0%
EPS, 5-year compound+7.0%

Shares and dividends

For fiscal 2025, as filed.

Diluted shares225M
Shares outstanding, 5-year compound−2.5%
Net share repurchases$2.55B
Dividend payout27.0%

Taxes

For fiscal 2025, as filed.

Income tax expense$1.05B
Effective tax rate15.6%

ELV in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.